# A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects

> **NCT04973189** · PHASE1 · COMPLETED · sponsor: **Shanghai Hengrui Pharmaceutical Co., Ltd.** · enrollment: 63 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** SHR-1707
- **DRUG:** Placebo
- **DRUG:** SHR-1707
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04973189
- **Lead sponsor:** Shanghai Hengrui Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-08
- **Primary completion:** 2022-01-13
- **Final completion:** 2022-01-13
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973189, "A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04973189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*